EDWARDS PERICARDIAL PATCH 4700 NA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 02 report with the FDA on 1997-07-25 for EDWARDS PERICARDIAL PATCH 4700 NA manufactured by Baxter Healthcare Corp. Edwards Cvs Division.

Event Text Entries

[18159842] This event was reported as dehiscence and infection. No further info was provided.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number6000002-1997-00629
MDR Report Key108052
Report Source02
Date Received1997-07-25
Date of Report1997-06-26
Date of Event1997-05-06
Date Mfgr Received1997-06-26
Device Manufacturer Date1996-12-01
Date Added to Maude1997-07-29
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameEDWARDS PERICARDIAL PATCH
Generic NamePERICARDIAL PATCH
Product CodeMFX
Date Received1997-07-25
Model Number4700
Catalog NumberNA
Lot Number6L1297
ID NumberNA
Device Expiration Date2000-12-01
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Age2 MO
Device Eval'ed by MfgrR
Implant FlagY
Date RemovedV
Device Sequence No1
Device Event Key106195
ManufacturerBAXTER HEALTHCARE CORP. EDWARDS CVS DIVISION
Manufacturer Address17221 RED HILL AVENUE IRVINE CA 92614 US
Baseline Brand NameEDWARDS PERICARDIAL PATCH
Baseline Generic NameNA
Baseline Model No4700
Baseline Catalog NoNA
Baseline IDNA
Baseline Device FamilyPERICARDIAL PATCH
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]48
Baseline PMA FlagN
Baseline 510K PMNY
Premarket NotificationK833763
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 1997-07-25

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.